COMBINATION CHEMOTHERAPY, TOTAL-BODY IRRADIATION, AND ALEMTUZUMAB IN TREATING PATIENTS UNDERGOING AN AUTOLOGOUS STEM CELL TRANSPLANT FOR STAGE I, STAGE II, STAGE III, OR STAGE IV CHRONIC LYMPHOCYTIC LEUKEMIA: